Agilent Tape Station Service Contract

The Centers for Disease Control and Prevention (CDC) is seeking a sole source purchase order for an annual service agreement with Agilent Technologies, Inc. for the Agilent TapeStation 4150 instruments. The agreement is necessary to ensure the valid management and proper usage of the instruments in the laboratories. The instruments are used to automate the Quality Control (QC) processes for RNA, DNA, and protein samples, which are critical to the research workflows. • The service agreement will provide genuine parts, services, and proprietary software support necessary for the TapeStations 4150. • Other providers lack access to Agilent's proprietary technologies and technical expertise and therefore cannot meet the operational requirements. • The estimated procurement amount is $8,953.52 per year, with a total of $26,860.56 for the base year and two option periods.